Stoke Therapeutics, Inc.

0GT.F·Frankfurt·Healthcare
Compare
23.73+0.20 (+0.85%)today
As of Nov 5, 8:01 AM CET · May be delayed up to 15 min · EUR

Prices may be delayed up to 15 min. Not investment advice. News volume: articles in the 4Search index each day.

Key statistics

Previous close23.53
Open23.73
Day range—
52-week range18.9032.80
Off day high0.00%
Off 52-week high−27.65%
Volume1.85K
Avg. volume (3M)41.00
Market cap1.55B
EPS (TTM)-3.28
Forward P/E-9.69
P/E ratio (TTM)—
Dividend yield—
Beta (5Y)1.38
Shares outstanding65.41M
Short interest—
Earnings dateOct 29, 2026
Analyst target—
Profit margin0.00%

Against its peers

Compare in full ›
0GT.F IRD DSGN SRPT 4591.T OCGN
Market cap 1.55B 355.25M 665.24M 2.01B 3.39B 296.72M
P/E (TTM) — — — — — —
Forward P/E -9.7 -6.0 -6.6 7.8 -1.1 -3.5
Price/book 4.9 -27.2 3.0 1.3 1.2 -16.8
Dividend yield — — — — — —
1-year change +20.05% +110.34% +54.73% +7.65% −29.21% −36.59%
Today +0.85% +8.65% +2.80% +2.43% −4.76% +17.35%

The closest companies by business and industry (Biotechnology). Prices may be delayed up to 20 min.

Related companies

Compare ›

The businesses closest to Stoke Therapeutics's by what they do, from their descriptions, with the same industry weighted in.

Company Mkt cap Price Today
Opus Genetics, Inc.IRD · Biotechnology 355.25M 4.2700 +8.65%
Design Therapeutics, Inc.DSGN · Biotechnology 665.24M 10.63 +2.80%
Sarepta Therapeutics, Inc.SRPT · Biotechnology 2.01B 18.99 +2.43%
Ribomic Inc.4591.T · Biotechnology 3.39B 60.00 −4.76%
Ocugen, Inc.OCGN · Biotechnology 296.72M 0.8745 +17.35%
4D Molecular Therapeutics, Inc.FDMT · Biotechnology 678.40M 12.28 +2.76%
uniQure N.V.QURE · Biotechnology 1.62B 23.03 −3.52%
Ultragenyx Pharmaceutical Inc.RARE · Biotechnology 1.75B 17.16 +3.19%

Also based in Bedford, Massachusetts, then elsewhere in Massachusetts.

Company Mkt cap Price Today
Lantheus Holdings, Inc.LNTH · Bedford, MA 6.60B 101.14 +0.34%
Novanta Inc.NOVT · Bedford, MA 5.49B 145.23 −1.53%
Ocular Therapeutix, Inc.OCUL · Bedford, MA 1.57B 7.14 +4.69%
Anika Therapeutics, Inc.ANIK · Bedford, MA 273.01M 20.40 +4.88%
The TJX Companies, Inc.TJX · Framingham, MA 159.23B 144.76 +5.18%
Vertex Pharmaceuticals IncorporatedVRTX · Boston, MA 139.20B 549.04 +3.44%
Moderna, Inc.MRNA · Cambridge, MAOdds 103.15B 258.38 +13.11%
American Tower CorporationAMT · Boston, MA 90.37B 194.86 +4.04%

The stocks whose daily moves over the past year went most closely with Stoke Therapeutics's: the correlation of their daily returns, where 1 would be moving as one.

Company Mkt cap Price Today
Stoke Therapeutics Inc0GT.MU · Correlation 0.83 — 23.73 +0.85%
Ultragenyx Pharmaceutical Inc.UP0.F · Correlation 0.34 1.54B 15.11 +8.86%

What visitors to Stoke Therapeutics's page also look at.

Company Mkt cap Price Today
Stoke Therapeutics Inc.0GT.MU — 23.73 +0.85%
Beam Global Inc.16NA.F 15.55M 0.6870 −0.79%
Annovis Bio Inc.07X.F 36.36M 0.8520 −12.26%
Raspberry Pi Holdings PLC0IK.F 1.17B 6.04 −2.03%
Mirum Pharmaceuticals Inc.08D.F 5.55B 84.98 +0.90%

From the 4Search instruments index: what each company does (its business description), its industry, size, headquarters and the markets it serves; and from a year of daily prices, which move together. Prices may be delayed up to 20 min.

Latest news

All 0GT.F news ›
Stoke Therapeutics··2 outletsPositive

Stoke Therapeutics Announces Completion of Successful Meeting with the FDA to Align on Planned U.S. NDA for Zorevunersen, an Investigational Medicine for the Treatment of Dravet Syndrome

– Analysis of the Phase 3 EMPEROR key secondary endpoint of changes in cognition and behavior will be performed using a multicomponent assessment of four Vineland-3 subdomains – – Phase 3 readout anticipated in the third quarter of 2027 to…

STOKPFE
More from 1 other outlet
Seeking Alpha·Positive

Stoke Therapeutics: The Market Misread A Key FDA Win

Explore Stoke Therapeutics (STOK) ahead of the 2027 zorevunersen Dravet readout—cash runway to 2028, FDA endpoint edge, and upside valuation. - Stoke Therapeutics is positioned for a pivotal 2027 readout of zorevunersen, potentially the…

LLYNVOPFESTOK
BioSpace··2 outlets

Stoke Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(C)(4) - October 16, 2026

BioSpace is the digital hub for life science news and jobs. We provide essential insights, opportunities and tools to connect innovative organizations and talented professionals who advance health and quality of life across the globe. The…

METADFTXACHV
More from 1 other outlet

From the 4Search news index, newest first.

In the news

21mentions in 30 days
21with it in the headline
Positivesentiment

Mentioned with

U.S. Food and Drug Administration12Stoke Media9Stoke Therapeutics, Inc7Stoke Therapeutics, Inc.7Pfizer6Eli Lilly5Novo Nordisk5Iovance Biotherapeutics4

People in the coverage

Ian F. Smith11Jason Hoitt8Aschettino7Zorevunersen6Barry Ticho5Aaron Kesselheim4

Themes

Healthcare11Massachusetts8Biotechnology6FDA6Health6Reports5Stok5Biotech4

Most coverage from

  1. marketscreener.com8
  2. seekingalpha.com3
  3. defenseworld.net2
  4. investor.stoketherapeutics.com2
  5. themarketsdaily.com2

Finance and business coverage in the 4Search news index: articles that name it in the headline, or in the text beside its ticker. Sentiment is the index's own reading of the latest 21 articles, not a forecast.

Market data is provided for information only and comes from free public sources. Prices may be delayed up to 15 minutes; data may be incomplete or inaccurate. Nothing on this page is investment advice or a recommendation to buy or sell any security. News and coverage analytics are drawn from the 4Search index. Terms of use. How to use Finance